Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Straumann Holding AG's operating assets for the quarter that ended in Dec. 2025 was CHF3,269 Mil. Straumann Holding AG's operating liabilities for the quarter that ended in Dec. 2025 was CHF1,174 Mil. Straumann Holding AG's Total Assets for the quarter that ended in Jun. 2025 was CHF3,512 Mil. Therefore, Straumann Holding AG's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.60.
Straumann Holding AG Scaled Net Operating Assets Related Terms
Straumann Holding AG Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG Scaled Net Operating Assets Chart
XSWX:STMN vs ISRG, BDX, MDLN: Scaled Net Operating Assets Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Scaled Net Operating Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.60 mean?
Straumann Holding AG (XSWX:STMN) has a Scaled Net Operating Assets of 0.60 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Straumann Holding AG and its competitors.
Is Straumann Holding AG's Scaled Net Operating Assets too high?
Straumann Holding AG's current Scaled Net Operating Assets is 0.60. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Scaled Net Operating Assets compare to ISRG and BDX?
Straumann Holding AG's Scaled Net Operating Assets of 0.60 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Straumann Holding AG and its competitors. Straumann Holding AG's current Scaled Net Operating Assets is 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current Scaled Net Operating Assets is 0.60. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Scaled Net Operating Assets is 0.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Scaled Net Operating Assets: 0.60
GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for XSWX:STMN
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
